Skip to content

Clinical trials

Observational Multiple Sclerosis, Relapsing-Remitting trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Observational Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20121
20131
20151
20173
20181
20191
20201
20214
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Unknown status3
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Biogen4
Heinrich-Heine University, Duesseldorf3
Merck KGaA, Darmstadt, Germany2
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Dr. med. Micha Loebermann1
Friedemann Paul1
Hoffmann-La Roche1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting19
Multiple Sclerosis10
Multiple Sclerosis, Chronic Progressive3
Disease Progression2
Carcinoma in Situ1
Fatigue1
Fatigue Syndrome, Chronic1
Influenza, Human1
Injection Site Reaction1
Sleep Wake Disorders1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.